Publication of data relating to relations between companies and healthcare operators

The collection of information useful for the research and development process is essential for a pharmaceutical company like Teva Italia, whose main objective is the health and well-being of patients. For this reason, collaborating with health professionals, specialists, general practitioners, health technicians, nurses and pharmacists is part of the daily work necessary to respond to people's care needs.

It is a collaboration that has already been well regulated for some time: these relationships, in fact, in addition to being governed by national and international standards, are based on mutual respect for roles and are placed in a transparent framework of strict ethical rules dictated by Farmindustria and guaranteed by precise investigative procedures presided over by magistrates indicated by the President of the Court of Cassation, as well as by the rules and procedures contained in the Assogenerici code of ethics.

The growing need for transparency and the ever-evolving digitization process move Teva Italia today to take a step further. From 30 June we have made available on our website the economic data relating to the collaboration relationships referred to the previous year with healthcare operators and organizations. Absolute transparency is the watchword that we are implementing now through the publication of the names of the healthcare professionals (even in associative forms) with whom we collaborate and the relative amounts paid to them for the aforementioned collaborations.

Teva Italia has in fact accepted with full conviction the Code on transparency (disclosure) implemented by Farmindustria, in implementation of the EFPIA Code (European Federation of Pharmaceutical Industries and Associations) and by Assogenerici, in implementation of the MEDICINES FOR EUROPE Code (European Association of Pharmaceutical Companies of generics and biosimilars).

The collaboration between drug companies and doctors is divided into various areas of activity, all aimed at sharing best clinical practices and exchanging information to better understand the therapeutic needs of patients and the treatment options available:

1. research and development of new drugs through clinical trials carried out in hospitals, universities and public and private healthcare facilities
   
   
2. scientific advice
   
   
3. scientific seminars and conferences, which offer information and updates
   
   
4. support for CME (Continuing Medical Education) congresses and courses organized by public facilities, universities, scientific societies and CME accredited providers

The data relating to transfers of value published here are those indicated by Art. 5 of the Farmindustria Code of Conduct. The publication of such data takes place according to the Model defined by the Code, taking into account the exclusions established by Farmindustria itself. This model and the data contained therein also comply with the requirements of Title V of the Assogenerici Code of Conduct implementing the Medicines for Europe Code, according to the provisions of the mutual recognition agreement of the respective Codes of Conduct that Farmindustria and Assogenerici signed on 7 March 2018

It is possible to access the data - published in full compliance with the Italian legislation on privacy - relating to the individual professionals who have signed the consent and - in aggregate form - to all the others, by accessing the dedicated pages.